These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35551600)

  • 1. Efficacy of atomoxetine plus oxybutynin in the treatment of obstructive sleep apnea with moderate pharyngeal collapsibility.
    Schweitzer PK; Maynard JP; Wylie PE; Emsellem HA; Sands SA
    Sleep Breath; 2023 May; 27(2):495-503. PubMed ID: 35551600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of atomoxetine plus a hypnotic on obstructive sleep apnea severity in patients with a moderately collapsible pharyngeal airway.
    Corser B; Eves E; Warren-McCormick J; Rucosky G
    J Clin Sleep Med; 2023 Jun; 19(6):1035-1042. PubMed ID: 36734173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atomoxetine and fesoterodine combination improves obstructive sleep apnoea severity in patients with milder upper airway collapsibility.
    Messineo L; Taranto-Montemurro L; Calianese N; Gell LK; Azarbarzin A; Labarca G; Vena D; Yang HC; Wang TY; Wellman A; Sands SA
    Respirology; 2022 Nov; 27(11):975-982. PubMed ID: 35811347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the Combination of Atomoxetine and Oxybutynin on OSA Endotypic Traits.
    Taranto-Montemurro L; Messineo L; Azarbarzin A; Vena D; Hess LB; Calianese NA; White DP; Wellman A; Sands SA
    Chest; 2020 Jun; 157(6):1626-1636. PubMed ID: 32006590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Combination of Atomoxetine and Oxybutynin Greatly Reduces Obstructive Sleep Apnea Severity. A Randomized, Placebo-controlled, Double-Blind Crossover Trial.
    Taranto-Montemurro L; Messineo L; Sands SA; Azarbarzin A; Marques M; Edwards BA; Eckert DJ; White DP; Wellman A
    Am J Respir Crit Care Med; 2019 May; 199(10):1267-1276. PubMed ID: 30395486
    [No Abstract]   [Full Text] [Related]  

  • 6. Combination of atomoxetine with the novel antimuscarinic aroxybutynin improves mild to moderate OSA.
    Rosenberg R; Abaluck B; Thein S
    J Clin Sleep Med; 2022 Dec; 18(12):2837-2844. PubMed ID: 35975547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The combination of atomoxetine and dronabinol for the treatment of obstructive sleep apnea: a dose-escalating, open-label trial.
    Messineo L; Norman D; Ojile J
    J Clin Sleep Med; 2023 Jul; 19(7):1183-1190. PubMed ID: 36805833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different antimuscarinics when combined with atomoxetine have differential effects on obstructive sleep apnea severity.
    Aishah A; Lim R; Sands SA; Taranto-Montemurro L; Wellman A; Carberry JC; Eckert DJ
    J Appl Physiol (1985); 2021 May; 130(5):1373-1382. PubMed ID: 33734828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Combination of Aroxybutynin and Atomoxetine in the Treatment of Obstructive Sleep Apnea (MARIPOSA): A Randomized Controlled Trial.
    Schweitzer PK; Taranto-Montemurro L; Ojile JM; Thein SG; Drake CL; Rosenberg R; Corser B; Abaluck B; Sangal RB; Maynard J
    Am J Respir Crit Care Med; 2023 Dec; 208(12):1316-1327. PubMed ID: 37812772
    [No Abstract]   [Full Text] [Related]  

  • 10. The norepinephrine reuptake inhibitor reboxetine alone reduces obstructive sleep apnea severity: a double-blind, placebo-controlled, randomized crossover trial.
    Altree TJ; Aishah A; Loffler KA; Grunstein RR; Eckert DJ
    J Clin Sleep Med; 2023 Jan; 19(1):85-96. PubMed ID: 36004739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The combination of atomoxetine and oxybutynin for the treatment of obstructive sleep apnea in children with Down syndrome.
    Combs D; Edgin J; Hsu CH; Bottrill K; Van Vorce H; Gerken B; Matloff D; La Rue S; Parthasarathy S
    J Clin Sleep Med; 2023 Dec; 19(12):2065-2073. PubMed ID: 37555595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One Month Dosing of Atomoxetine plus Oxybutynin in Obstructive Sleep Apnea: A Randomized, Placebo-controlled Trial.
    Aishah A; Loffler KA; Toson B; Mukherjee S; Adams RJ; Altree TJ; Ainge-Allen HW; Yee BJ; Grunstein RR; Carberry JC; Eckert DJ
    Ann Am Thorac Soc; 2023 Apr; 20(4):584-595. PubMed ID: 36538809
    [No Abstract]   [Full Text] [Related]  

  • 13. The effects of atomoxetine and trazodone combination on obstructive sleep apnea and sleep microstructure: A double-blind randomized clinical trial study.
    Shahbazi M; Heidari R; Tafakhori A; Samadi S; Nikeghbalian Z; Amirifard H; Najafi A
    Sleep Med; 2024 Jan; 113():13-18. PubMed ID: 37979502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the combination of atomoxetine and oxybutynin in Japanese patients with obstructive sleep apnoea: A randomized controlled crossover trial.
    Kinouchi T; Terada J; Sakao S; Koshikawa K; Sasaki T; Sugiyama A; Sato S; Sakuma N; Abe M; Shikano K; Hayama N; Shiko Y; Ozawa Y; Ikeda S; Suzuki T; Tatsumi K
    Respirology; 2023 Mar; 28(3):273-280. PubMed ID: 36184258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical polysomnographic methods for estimating pharyngeal collapsibility in obstructive sleep apnea.
    Vena D; Taranto-Montemurro L; Azarbarzin A; Op de Beeck S; Marques M; Vanderveken OM; Edwards BA; Gell L; Calianese N; Hess LB; Radmand R; Hamilton GS; Joosten SA; Verbraecken J; Braem M; White DP; Redline S; Sands SA; Wellman A
    Sleep; 2022 Jun; 45(6):. PubMed ID: 35238379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stepwise Add-On and Endotype-informed Targeted Combination Therapy to Treat Obstructive Sleep Apnea: A Proof-of-Concept Study.
    Aishah A; Tong BKY; Osman AM; Pitcher G; Donegan M; Kwan BCH; Brown E; Altree TJ; Adams R; Mukherjee S; Eckert DJ
    Ann Am Thorac Soc; 2023 Sep; 20(9):1316-1325. PubMed ID: 37159953
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of oxybutynin and reboxetine on obstructive sleep apnea: a randomized, placebo-controlled, double-blind, crossover trial.
    Berger M; Solelhac G; Marchi NA; Dussez R; Bradley B; Lecciso G; Heiniger G; Bayon V; Van Den Broecke S; Haba-Rubio J; Siclari F; Heinzer R
    Sleep; 2023 Jul; 46(7):. PubMed ID: 36861433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reboxetine Plus Oxybutynin for OSA Treatment: A 1-Week, Randomized, Placebo-Controlled, Double-Blind Crossover Trial.
    Perger E; Taranto Montemurro L; Rosa D; Vicini S; Marconi M; Zanotti L; Meriggi P; Azarbarzin A; Sands SA; Wellman A; Lombardi C; Parati G
    Chest; 2022 Jan; 161(1):237-247. PubMed ID: 34543665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addition of zolpidem to combination therapy with atomoxetine-oxybutynin increases sleep efficiency and the respiratory arousal threshold in obstructive sleep apnoea: A randomized trial.
    Messineo L; Carter SG; Taranto-Montemurro L; Chiang A; Vakulin A; Adams RJ; Carberry JC; Eckert DJ
    Respirology; 2021 Sep; 26(9):878-886. PubMed ID: 34164887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Venlafaxine on Apnea-Hypopnea Index in Patients With Sleep Apnea: A Randomized, Double-Blind Crossover Study.
    Schmickl CN; Li Y; Orr JE; Jen R; Sands SA; Edwards BA; DeYoung P; Owens RL; Malhotra A
    Chest; 2020 Aug; 158(2):765-775. PubMed ID: 32278781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.